Skip to main content

Table 1 Comparison of patient characteristics among the two study groups

From: Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility

 

TSH 0.27–2.5 mIU/L

n = 543

1110 cycles

TSH 2.51–4.5 mIU/L

n = 183

355 cycles

 

Age (years)*

29 (19–40)

29 (19–40)

0.07

Age range

  < 35

476 (87.6%)

160 (87.4%)

0.85

   ≥ 35

67 (12.4%)

23 (12.6%)

 

Body mass index (kg/m2)*

24.2 (18.2–34.8)

23.4 (18.1–34.8)

0.08

Body mass index range

   

   < 25

316 (58.2%)

119 (65.0%)

0.67

  25–29.9

182 (33.5%)

53 (28.9%)

 

  ≥ 30

45 (8.2%)

11 (6.1%)

 

Primary infertility

466 (85.8%)

303 (85.5)

0.92

Infertility duration (years)*

4.02 (2–9)

4.44 (2–10)

0.38

Infertility duration range

   

   < 3 years

165 (30.5%)

57 (31.1%)

0.78

  3–5 years

212 (39.0%)

79 (43.1%)

 

  > 5 years

166 (30.5%)

47 (25.6%)

 

History of pelvic surgery

77 (14.1%)

27 (14.7%)

0.84

Smokers, n

104 (19.3%)

36 (19.8%)

0.87

Smoking ranges

   

   1–5 cigarettes/day

42 (7.7%)

12 (6.5%)

0.71

  6–10 cigarettes/day

45 (8.2%)

18 (9.8%)

 

  > 10 cigarettes/day

17 (3.1%)

6 (3.2%)

 

Alcohol use, n

8 (1.4%)

4 (2.1%)

0.547

Basal assessment on day 2

   

  FSH level (IU/L)*

6.8 (2.4 -9.9)

6.8 (1.8–10.0)

0.801

  Prolactin, ng/mL *

14.0 (4–30)

14.1 (5–30)

0.100

  LH level (IU/L) *

4.8 (0.8–40.0)

5.1 (1.4–41.0)

0.091

  Antral follicle count, n*

9 (8–23)

9 (8–24)

0.128

Total motile sperm count (millions) *

43 (10–346)

41 (10–330)

0.835

  1. TSH, thyroid stimulating hormone; FSH, follicle stimulating hormone; LH, luteinizing hormone
  2. *Values are median (25th–75th percentile)